Assertio to Participate in the HC Wainwright and Lake Street Conferences in New York City September 10-12, 2024

Rhea-AI Summary

Assertio Holdings, Inc. (Nasdaq: ASRT), a pharmaceutical company, has announced its participation in two upcoming investor conferences in New York City. Ajay Patel, the company's Chief Financial Officer, will host investor meetings at both events:

1. The HC Wainwright Conference from September 10-11, 2024, at the Lotte New York Palace Hotel.

2. The Lake Street Capital Markets BIG8 Conference on September 12, 2024, at the Yale Club.

Investors interested in meeting with Assertio can register and request meetings through their respective HC Wainwright or Lake Street representatives. This participation demonstrates Assertio's commitment to engaging with investors and showcasing their comprehensive commercial capabilities in offering differentiated pharmaceutical products to patients.

LAKE FOREST, Ill., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced that Ajay Patel, Chief Financial Officer, will host investor meetings at two investor conferences taking place in New York City during September 10-12, 2024.

Assertio will participate in the HC Wainwright Conference, which will take place September 10-11, 2024 at the Lotte New York Palace Hotel. Investors can register and request meetings via their HC Wainwright representative.

The Company will also participate in the Lake Street Capital Markets BIG8 Conference, taking place September 12, 2024 at the Yale Club. Investors can register and request meetings through their Lake Street representative.

About Assertio

Assertio is a commercial pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients. We have built our commercial portfolio through acquisition or licensing of approved products. Our commercial capabilities include marketing through both a sales force and a non-personal promotion model, market access through payor contracting, and trade and distribution. To learn more about Assertio, visit www.assertiotx.com. 

Investor Contact

Matt Kreps, Managing Director
Darrow Associates
M: 214-597-8200
mkreps@darrowir.com

FAQ

When and where is Assertio (ASRT) participating in investor conferences in September 2024?

Assertio (ASRT) is participating in two investor conferences in New York City: the HC Wainwright Conference from September 10-11, 2024, at the Lotte New York Palace Hotel, and the Lake Street Capital Markets BIG8 Conference on September 12, 2024, at the Yale Club.

Who will represent Assertio (ASRT) at the September 2024 investor conferences?

Ajay Patel, Chief Financial Officer of Assertio (ASRT), will host investor meetings at both conferences in New York City.

How can investors request meetings with Assertio (ASRT) at the September 2024 conferences?

Investors can register and request meetings with Assertio (ASRT) through their HC Wainwright representative for the HC Wainwright Conference, and through their Lake Street representative for the Lake Street Capital Markets BIG8 Conference.

What type of company is Assertio (ASRT)?

Assertio (ASRT) is a pharmaceutical company with comprehensive commercial capabilities that offers differentiated products to patients.